Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_759_Библиотеки_им_академика_М_И_Перельмана.pdf
476
Index
Ileal conduit urinary diversion (cont.)
ileus and bowel obstruction, 160
infection, 159, 160
metabolic disturbances, 161, 162
parastomal hernias, 157, 158
sexual side effects and quality of life impact, 162
stomal stenosis, 158, 159
stoma-related complications, 157
ureterointestinal strictures, 159
Ileal reservoir, 149
Ileocaecal reservoir, 146–148
Ileus/bowel obstruction, 138, 433
Impaired perineal wound healing, 389–391
Infertility
bleeding and hysterectomy
blood loss, 43
management, 46–47
prevention, 43, 45
recognition, 45
IUA, 47, 48
ovarian reserve and loss of ovary, 55, 56
uterine perforation, 49, 50
uterine rupture and abnormal placentation, 51, 52
volume overload, hysteroscopic procedures, 52–55
Inammatory bowel disease (IBD)
early postoperative complications
anastomotic/pouch leaks and pelvic abscesses,
267–269
SSIs, 267
intraoperative complications
reproductive organs, 265, 266
ureter and bladder injury, 265
vessels, 266, 267
late postoperative complications
anastomotic/pouch stulas, 269–271
entrapped ovary, 273
infertility, 271, 272
sexual dysfunction, 272
unhealed perineal wound, 272, 273
Inguinal lymphadenectomy, 340
Inguinofemoral lymphadenectomy (IFL)
early and aggressive surgical resection, 340
infection, 340
management of lymphedema, 338
physiologic surgical options, 338
prevention of lymphedema, 334, 335
surgical management of lymphedema, 338
surgical site complications, 340
vascularized lymph nodes, 338
Intermittent self-catheterization (ISC), 369
Internal iliac venous plexus, 352
International Study Group of Rectal Cancer, 401
Interstitial pregnancy, 306
Intestinal anastomosis, 138
Intraoperative ap perfusion, 467
Intrauterine adhesive disease (IUA)
management, 48
prevalence, 47
prevention, 47
recognition, 48
Intrauterine pregnancy (IUP), 301, 305
Introital stenosis, 345
Intussusception, 176, 177
Inversion of the uterine corpus, 296, 297
L
Laceration of the vaginal wall, 277
Laparoendoscopic single-site surgery (LESS), 337
Laparoscopic entry and complications, 304
Laparoscopy, 303
Large bowel obstruction (LBO), 394
Large infected presacral uid collection, 391
Lateral pelvic sidewall neurovascular exposure, 446
Lateral venorrhaphy, 354
LigaSure technology, 339
Ligation of intersphincteric stula tract (LIFT), 212, 213,
216
Local excision for anal squamous cell cancer, 387
Low anterior resection syndrome (LARS), 410–412
Lower extremity lymphedema (LEL), 333
Lumbopelvic stabilization, 453
Lumbosacral plexus, 286
Lundiana pouch, 146
Lymphadenectomy, 351, 353
Lymphaticovenular anastomosis, 338
Lymphatic system, 352
Lymphedema, 356, 435, 436
Lymphocyst, 360
Lymphovenous anastomosis (LVA), 337
Lymphovenous bypass, 338
M
Major hemorrhage, 430
Major nerve (sciatic or femoral) resection, 445
Major pelvic bone tumor resections, 451
Malabsorption, 143
Malnutrition
clinical assessments, 31–33
consequences, 33, 34
denition, 31
gastrointestinal anatomic and functional alterations, 34
neoadjuvant therapy, 34, 35
preoperative malnutrition
gut microbiome, 35
mitigation, 35, 36
prevalence, 33
Marshall-Marchetti-Krantz (MMK) procedure, 90
Massive hemorrhage, hemodynamic instability, 303–304
Massive obstetric hemorrhage, 321–325
Meatal stenosis, 105, 106
Mechanical bowel preparation (MBP), 14
Mechanical complications, 455
Mechanical tamponade, 293
Mechanism of venous injury, 283
Mechanism of venous laceration, 285
Mesenchymal stem cells (MSCs), 216
Mesentery of the sigmoid colon, 358, 359
Metabolic disturbances, 161, 162
Index
477
Metabolic imbalance, 143
Methotrexate, 302, 305
Microsurgical anastomosis, 337
Microsurgical lymphatic bypass, 356
Midurethral slings (MUS), 84–88
bladder injury, 85
De Novo Irritative Voiding Symptoms, 88
mesh erosion, 85
pain, 85, 88
recurrent incontinence, 88
SIS, 85
TOT, 84, 85
TVT, 84
voiding dysfunction, 88
Mild lymphedema, 356
Minimally invasive surgery
incision site hernia, 250, 251
obesity, 251
surgical energy and thermal injury, 248–250
Trendelenburg complications, 252
trocar injury, 245–248
Mitrofanoff procedure, 150
Mixed augmentation ileum and caecum (MAINZ) pouch
I, 146
Modied radical vulvectomy
IFL, 339
and inguinal lymphadenectomy, 333
Muscle ap transposition, 391
Muscle transfer techniques, 344
N
Narcotic pain, 15
Nasogastric (NG) tubes, 15
Necrotizing infection, 299, 339
Negative-pressure wound therapy (NPWT), 340
Neobladders
early postoperative complications
ileus/bowel obstruction, 138
intestinal anastomosis, 138
perioperative bleeding, 137
urological anastomosis and suture lines, 138, 139
UTI, 140
vesicovaginal stula, 139
indication, 137
long-term complications
malabsorption, 143
metabolic imbalance, 143
pelvic organ prolapse, 142, 143
psychological effects, 143
sexual dysfunctions, 142
short bowel syndrome, 143, 144
urinary incontinence, 140, 141
urinary retention, 141, 142
urinary strictures, 141, 142
urinary tract infections, 143
urinary diversions, 137
Neostigmine, 16
Nephrostomy tubes, 433
Nerve injury, 356, 357, 449, 450
and complication, 445–447
genital tract prolapse, 76–78
Neurologic injury, 285, 286, 451
Neurosurgery, 441
Non-diagnostic laparoscopy, 304
Non-gynecologic tumors in the female pelvis, 276–277
Non-muscle invasive BCa (NMIBC), 117
Non-tubal ectopic pregnancy, 305–307
Non-urogynecological pelvic masse, 276
O
Obesity, 251
Obstetric anal sphincter injury (OASIS), 221
Obstetric hemorrhage, 320
Obturator nerve, 450, 451
Obturator neuropathy, 357
Open/laparoscopic surgery, 351
Orthopaedic surgery consultation, 454
Orthotopic neobladder, 140, 141, 143
Osteomyelitis, 455, 456
Ovarian cancer, composite pelvic resection
anastomotic bleeding, 384
anastomotic leak, 381–383
anastomotic stricture, 384, 385
bowel injury, 383, 384
post-operative hemorrhage/hematomas, 378, 379
ureteral injury, 379, 380
vascular injury, 377
Ovarian sparing surgery for ovarian ectopic pregnancies,
307
Ovaries, 422
P
Palliative exenteration, 427
Parastomal hernias, 157, 158
Partial cystectomy (PC)
advantages, 123
complications, 125, 126
contraindications, 123
indications, 123
oncological outcomes, 126, 127
preoperative work-up, 124
surgical technique, 124, 125
Partial/total ap loss, 469–470
Pedicled and free aps, 468
Pedicled omentoplasty, 335
Pelvic abscess, 372, 401, 434
Pelvic and paraaortic lymphadenectomy (PPLND)
arterial embolization, 360
chylous ascites, 361
complications, 351
duodenum, 359, 360
lymphedema, 356
lymphocyst, 360
mesentery of the sigmoid colon, 358, 359
nerve injury, 356, 358
ureteral injuries, 358
vascular injury, 352, 353, 356
478
Index
Pelvic and paraaortic lymph node removal, 351
Pelvic cancer, 455–458
Pelvic defect reconstruction with aps, 464
Pelvic exclusion techniques, 393
Pelvic exenteration (PEx)
circumferential resection margin, 427
decision-making process, 429, 436
delayed complications, 434, 435
description, 427
early complications, 432–434
indications, 427
infection risk, 431
intra-operative complications, 429–432
morbidity, 427
multidisciplinary team (MDT) coordination, 429
parastomal hernia, 436
post-operative complications, 427, 432
pre-operative considerations, 429
prevention, early recognition and comprehensive
treatment of complications, 429
psychological support, 429
radiation therapy, 427
risk modication strategies, 429
scrub teams, 429
surgical site infection/collection, 429
Pelvic oor physical therapy and biofeedback, 411
Pelvic uid collections/abscess/organ space infection,
387, 391, 392
Pelvic girdle tumors, 454
Pelvic lymphadenectomy, 351, 356
Pelvic lymph node dissection (PLND), 13
Pelvic organ prolapse, 142, 143
Pelvic Organ Prolapse Quantication system (POP-Q),
341
Pelvic radiotherapy, 417–424
Pelvic reconstructive procedures
anatomic area, 463
bulge/herniation formation, 467
complication rate, 464
early identication, 468
extirpative and reconstructive phases, 463
free tissue transfer, 466
operative procedures, 465
patient examination, 464
perforator aps, 464
periumbilical perforators, 466
postoperative activity modication and positioning,
467
post-operative antibiotics, 468
pre-operative evaluation, 464
prevention and mitigation of, 464
primary closure, 463
prophylactic intravenous antibiotics, 465
risk factors, 464
skin grafts, and aps, 463
wide surgical preparation and draping of the pelvis
and donor sites, 465
Pelvic resection for gynecologic malignancies, 439
Pelvic ring and acetabulum, fractures, 454, 455
Pelvic sidewall disease, 440
Pelvic sidewall tumor, 447
Percutaneous tibial nerve stimulation (PTNS), 227
Perianal abscess, 207–209
Perianal cancer without sphincter involvement, 389
Perianal pain, 435
Perineal dehiscence, abdominal perineal resection for
anal cancer, 278
Perineal hernia, 278, 387, 392, 393
Perineal wound
complications, 387
dehiscence, 390
Peritonitis, 433
Persistent ectopic pregnancy (PEP), 305
Placenta accreta, 312
Placenta accreta spectrum (PAS), 319, 321–324, 327, 328
Plastics reconstruction, 432, 435, 436, 441
Positive pregnancy test, 303
POSSUM score, 429
Postabortal infection, 315
Post-abortion hemorrhage, 309
Post-cesarean infections, 298, 299
Posterior tibial nerve modulation, 344
Postoperative groin cellulitis, 339
Postoperative sexual function, extensive perineal
excision, 343
Postpartum hemorrhage, 292, 293
Post-polypectomy syndrome, 191, 194
Preoperative relational dissatisfaction, 345
Presacral sinuses, 273
Presacral venous bleeding, 409, 410
Presacral venous plexus (PVP), 444
Pressure sores, 434
Primary anal reconstruction, 342
Primary haemorrhage, 432
Primary urethral cancers (PUC), 103
Procidentia, see Rectal prolapse
Progressive obstructive symptoms complications, 394
Progressive vaginal stenosis, 436
Propensity score matched analysis, 339
Prophylactic antibiotics, 197
Prophylactic use of endovascular interventions, 322
Psychosexual, 435
Pubovaginal slings (PVS), 110, 111
bladder perforation, 89
De Novo Irritative Voiding Symptoms, 89
fascia lata, 112
overview, 88, 89
rectus sheath, 112, 113
recurrent incontinence, 90
sling erosion, 113
urinary retention, 89
Pudendal nerve, 450
damage, 450
injury, 451
terminal motor latencies, 344
Pudendal neuropathy, 344
Index
479
Q
Quality of life, 435
R
Radiation associated sarcomas, 459–460
Radiation-induced bladder and urinary acute effects, 419
Radiation osteitis, 458
Radiation proctitis, 421
Radiation therapy, female pelvic malignancies, 417
Radiation toxicity, 420
incidence and severity, 419
in the large bowel/rectum, 420
Radiation treatment
acute toxicities, 417, 419
late toxicities, 417, 419, 420
Radical cystectomy
bladder cancer, 129
complications, 130
bleeding/thromboembolic, 131, 132
cardiopulmonary, 131
gastrointestinal, 131
genitourinary, 130
infection, 130
lymphocele, 132
neurologic, 132
organ-sparing cystectomy, 133
ovary removal risks, 133
vaginal, 133
surgical approach, 129, 130
Radical hysterectomy, 365
blood supply of ureter, 366
complications, 363
bladder dysfunction, 366–369
colorectal dysfunction, 369, 370
rectal injury, 367
sexual dysfunction, 372, 373
surgical site infection, 370–372
urinary tract injury, 364, 365
vaginal dehiscence, 370
neuroanatomy, 368
oncologic resection of a pelvic malignancy, 363
ureter through the parametrium, 364
Radical lymphadenectomy, 340
Radical vulvar surgery, 341
Radical vulvectomy, 342
functional impairments, 341, 342
IFL, 339
infection, 340
loco-regional recurrence after wide local excision,
345
and lymphadenectomy, 339
NPWT, 340
surgical debridement, 340
vacuum-assisted closure in complex wound failures,
340
Radiofrequency tissue remodeling, 226
Radionuclide lymphoscintigraphy, 333
Reconstructive surgery, 342
Rectal carcinoma, 401–403, 405, 406, 408–410, 412, 414
Rectal hyposensitivity, 223
Rectal injury, 367, 431
Rectal prolapse
abdominal procedures, 232–233
abdominal surgery complications, 233, 234
anastomotic leaks, 237
denition, 231
diagnosis, 231
discitis, 236, 237
hemorrhagic complications, 234, 235
intraabdominal collections/ seromas/ abscess, 237
mesh complications, 235, 236
multicompartment prolapse repairs, 239
perineal surgery, 238, 239
postoperative constipation/fecal impaction, 239
postoperative pain, 238
preoperative procedures, 232
risk factors, 231
SBO, 237
surgical repair, 231
ureteral injury, 237
Rectopexy, 234, 235
Rectosigmoid anastomosis, 381
Rectosigmoid carcinoma, 401–404, 406, 408–410, 412,
413
Rectosigmoid junction, 397, 398
Rectovaginal stulas (RVFs), 395, 396
Rectus muscle ap, 390
Recurrent and metastatic lesions, 458–459
Recurrent ectopic pregnancy (REP), 305
Recurrent pelvic sidewall tumor resection
extended surgical resection, 439
management, 439
recurrence, 439
recurrent pelvic sidewall tumors, 440
surgical approaches, 439
Regional anesthesia, 15
Renal impairment, 434, 436
Residual pregnancy tissue/blood products, 315
Retropubic suspensions, 90
Right pedicled anterolateral thigh with an extended skin
paddle, 467
Right pedicled gracilis muscle ap, 470
Robot-assisted RC (RARC), 15
Robotic-assisted video-endoscopic inguinal
lymphadenectomy (RAVEIL), 337
Ruptured ectopic pregnancy, 303, 304
S
Sacral nerve neuromodulation (SNM), 227
Sacral nerve stimulation, 344, 414
Sacral resection, 453
Sacral transection, 430
Sacrectomy, 431, 451, 453, 454
Salpingectomy, 305
480
Index
Salpingostomy, 305
Saphenous vein preservation, 335
Sarcoma, 275
Sciatic nerve, 449
Secondary lymphedema after lymphadenectomy, 333
Sentinel lymph node (SLN) dissection, 333
mapping, 338
sampling, 339
Sexual dysfunction, 142, 272, 341, 372, 373
physiological changes, 345
rectal cancer treatment, 412, 413
vulvar cancer, 345
Sexual intercourse, 277
Short bowel syndrome, 143, 144
Simple cesarean hysterectomy, 319, 320
Single incision laparoscopic surgery (SILS), 250
Single incision slings (SIS), 85
Sinus tract marsupialization, 405
Skin toxicity, 421
Small bowel, 420
Small bowel obstruction (SBO), 237, 387, 393, 394
SolestaR injection, 226
Sphincteroplasty, 344
Staccato tapping, 118
Stomal problems, 433
Stomal stenosis, 158, 159
Stress urinary incontinence (SUI), 368
denition, 83
female urethrectomy, 107–112
injectable therapy, 83, 84
MUS, 84–88
bladder injury, 85
De Novo Irritative Voiding Symptoms, 88
mesh erosion, 85
pain, 85, 88
recurrent incontinence, 88
SIS, 85
TOT, 84, 85
TVT, 84
voiding dysfunction, 88
PVS
bladder perforation, 89
De Novo Irritative Voiding Symptoms, 89
overview, 88, 89
recurrent incontinence, 90
urinary retention, 89
retropubic suspensions
Burch procedure, 90
overview, 90
recurrent incontinence, 90
voiding dysfunction, 90
urethral diverticulectomy, 97, 98
Subclinical AL, 405
Subjective Global Assessment (SGA), 31
Suction-assisted lipectomy, 338
Suction thrombectomy, 8
Supercial uid collections, 468
Supercial infection, 468
Supralevator abscesses, 207
Supralevator exenterative procedure, 432
Suprasphincteric stulas, 210
Surgical abortion, 309, 310, 312–316
Surgical oncology, 441
Surgical site infection (SSI), 267, 298, 320, 321,
370–372
Surgical wound complications, 460
Sustained thermal injury, 281
Suture rectopexy (SR), 237
Sympathetic and parasympathetic nerve injuries, 286
Symptomatic strictures, 397, 398
T
Tamoxifen, 4
Tension-free vaginal tape (TVT), 84
Thermal damage, 364
Thermal injury, 365
Thrombo-embolic problems, 434
Thrombolysis, 8
Traction/compression injury, 286
Transanal local excision (TAE)
abscess
management, 198
prevention, 197
recognition, 197
surgical site infections, 197
bleeding
management, 196
prevention, 195, 196
recognition, 196
risk factors, 195
conventional retractors and sutures, 189
EMR and ESD, 190
fecal incontinence, 200
management, 201
prevention, 200
recognition, 201
risk factors, 200
perforation
delayed perforations, 191
ESD, 191
intra-procedural perforations, 190
management, 194, 195
post-polypectomy syndrome, 191
prevention, 191–194
recognition, 194
polyps, 189
screening, 189
strictures, 198–200
TAMIS, 189, 190
urinary retention, 201, 202
Transanal minimally invasive surgery (TAMIS), 189,
190, 192, 193, 195, 200
Transobturator tape (TOT), 84, 85
Transsphincteric stulas, 209, 210
Transurethral macroplastique injection, 110, 111
Transurethral resection of a bladder tumor (TURBT)
bleeding and reoperation/transfusion, 119, 120
non-infective cystitis and voiding discomfort, 120,
121
Index
481
perforation, 117, 118
risk factors, 117
symptom, 117
UTIs, 120
Transvaginal marsupialization, 95
Trauma and extensive extirpative gynecologic, urologic
and/or colorectal surgery for malignancy, 463
Trendelenburg complications, 252
Trocar injury, 245–248
Trocar site hernia, 250, 251
Tubal ectopic pregnancy, 301–305
Tubal rupture and hemoperitoneum, 304
Tumor of female pelvis, 275, 276
Tumors of bony pelvis, 449
Turnbull-Cutait technique, 217
U
Uncontrolled obstetric hemorrhage, 320
Underwater EMR (UEMR), 192
Unfractionated heparin, 7
Unhealed perineal wound, 272, 273
Unilateral/bilateral lower extremity edema, 356
Unilateral/bilateral rhomboid aps/local advancement
aps, 342
Unintended hysterotomy extension, 294–296
Unintended nerve injury, 446
Ureteral avulsion, 176, 177
Ureteral endometriosis (UE), 257, 258
Ureteral injury, 66, 67, 358, 363, 365, 366
anatomy, 167
DIE, 255, 256, 258, 259
management
bladder ap, 171
delayed recognition, 169
methylene blue, 168
mucosal apposition, 169
non-reuxing anastomosis, 171, 172
perforation, 168
psoas hitch, 169
reconstruction, 169
penetrating trauma, 167
prevention and evaluation, 168
Ureteral stents, 442
Ureteral stricture, 435
Ureteral wall injury, 176
Ureterointestinal strictures, 159
Ureteroscopy
early postoperative complication
intravascular stent misplacement, 180
pain and ureteral obstruction, 179
post obstructive diuresis, 180
premature labor, 179
ureteral stent discomfort, 179
ureteral stent migration, 180
urinoma, perirenal abscess and hematomas, 178
UTI and sepsis, 178, 179
vascular anomalies, 178
intraoperative complication
access, 177
bleeding, 177
ureteral avulsion and intussusception, 176, 177
ureteral wall injury, 176
late postoperative complication
neglected stents, 181, 182
ureteral stricture, 181
upper urinary tract, 175
Ureters (brosis), 431
Urethral bulking agent (UBA), 83, 84
Urethral diverticulectomy (UD)
complications, 97
diagnosis, 94, 95
differential diagnosis, 95
excision and reconstruction, 96, 97
indications, 95
pathophysiology, 93
prevalence and presentation, 94
recurrences, 99, 100
stress urinary incontinence, 97, 98
stricture, 99
surgical management, 95
urethrovaginal stula, 98, 99
Urethral eversion, 344, 345
Urethrovaginal stula, 98, 99
Urinary diversion (UD), 13, 16, 431, 433
Urinary dysfunction, 412, 413
Urinary incontinence, 140, 141, 341
anatomical distortions, 344
sympathetic nerve injury, 412
Urinary injury, 280, 281
Urinary leak, 433
Urinary retention, 141, 142, 201, 202
Urinary strictures, 141, 142
Urinary tract infections (UTIs), 16, 372
neobladders, 140, 143
ureteroscopy, 178, 179
Urinary tract injury
complications, 442, 443
genital tract prolapse, 75, 76
Urine/bowel contents, 298
Urinomas, 380
Urologic Injury, 327
Urological practice, 429
Urology, 441
Uterine artery embolization (UAE), 293, 307
Uterine atony, 309, 310
Uterine injury, 314
Uterine perforation, 49, 50, 314
Uterine rupture, 51, 52, 296
Uterine scar dehiscence, 296
Uterine scar rupture, 319
Uterus damage, 422
“Utra-radical” resection strategies, 439
V
Vacuum assisted closure (VAC) dressings, 391
Vaginal bowel control systems, 225, 226
Vaginal cuff dehiscence, 68, 69
Vaginal dehiscence and evisceration, 370
482
Index
Vaginal effects, pelvic XRT, 423
Vaginal lubrication, 412
Vaginal preparation, hysterectomy, 339
Vascular injury, 282, 352–355, 451–453
and complications, 443–445
during resection of pelvic tumors, 282, 285
Vascular ligation techniques, 293
Vascular/lymphatics/nerves, radiation, 423, 424
Vascular sclerosis, 420
Vascular surgery, 441
Venous injury, 283
Venous thromboembolism (VTE)
diagnosis, 6, 7
epidemiology, 3
prevention, 4–6
risk factors, 3, 4
treatment, 7–9
Ventral mesh rectopexy (VMR), 228, 235
Vertical rectus abdominus myocutaneous (VRAM) ap,
389, 390, 466
Vesicovaginal stula, 139
Video-assisted anal stula treatment (VAAFT), 214
Video-endoscopic inguinal lymphadenectomy (VEIL),
337
Vitamin B12 deciency, 143
Vitamin K antagonists, 7
Vulvar reconstruction, 342
Vulvectomy, 333, 338, 340, 341
Vulvovaginal carcinoma surgery, 342
Vulvovaginal oncologic surgery, 343
Vulvovaginal reconstruction, 342
V-Y advancement gluteal fold ap, 342
W
Wexner fecal incontinence scale, 342
WHO checklist, 429–432
Wound breakdown, 339
Wound dehiscence
and delayed wound healing, 468, 469
and supercial infection, 460, 461
Wound infection, 299, 339